95 related articles for article (PubMed ID: 25906122)
1. Prognostic Significance of Apoptosis-related Markers in Patients With Soft-Tissue Sarcomas of Extremities.
Mühlbeier DF; Saddi VA; de Paula ÉC; Cunha IW; Fregnani JH; Barbosa MA; Manoel WJ
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):268-74. PubMed ID: 25906122
[TBL] [Abstract][Full Text] [Related]
2. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of p53, Mdm2, p21(WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with histologic grade.
Sabah M; Cummins R; Leader M; Kay E
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):64-9. PubMed ID: 17536310
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of apoptosis-related markers TP53, BCL-2, BAX and c-MYC in female genital tract sarcomas.
Liu FS; Jan YJ; Lai CR; Twu NF; Lu CH; Hung MJ; Hsieh YT; Chiou LC
J Chin Med Assoc; 2008 Dec; 71(12):628-34. PubMed ID: 19114327
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlations with prognosis.
Nakanishi H; Ohsawa M; Naka N; Uchida A; Ochi T; Aozasa K
Oncology; 1997; 54(3):238-44. PubMed ID: 9143406
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and expression of its regulatory proteins in soft tissue sarcomas.
Dan'ura T; Kawai A; Morimoto Y; Naito N; Yoshida A; Inoue H
Cancer Lett; 2002 Apr; 178(2):167-74. PubMed ID: 11867201
[TBL] [Abstract][Full Text] [Related]
7. Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer.
Baekelandt M; Holm R; Nesland JM; Tropé CG; Kristensen GB
J Clin Oncol; 2000 Nov; 18(22):3775-81. PubMed ID: 11078490
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins.
Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M
Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935
[TBL] [Abstract][Full Text] [Related]
9. Expression of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma.
Singh L; Pushker N; Saini N; Sen S; Sharma A; Bakhshi S; Chawla B; Kashyap S
Clin Exp Ophthalmol; 2015 Apr; 43(3):259-67. PubMed ID: 25132102
[TBL] [Abstract][Full Text] [Related]
10. Survivin expression in breast carcinoma: correlation with apoptosis and prognosis.
Nassar A; Sexton D; Cotsonis G; Cohen C
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):221-6. PubMed ID: 18301249
[TBL] [Abstract][Full Text] [Related]
11. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma.
Sun B; Sun Y; Wang J; Zhao X; Wang X; Hao X
Eur J Cancer Prev; 2006 Jun; 15(3):258-65. PubMed ID: 16679870
[TBL] [Abstract][Full Text] [Related]
12. Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma.
de Vicente JC; Olay S; Lequerica-Fernandez P; Sánchez-Mayoral J; Junquera LM; Fresno MF
J Oral Pathol Med; 2006 Mar; 35(3):140-5. PubMed ID: 16454809
[TBL] [Abstract][Full Text] [Related]
13. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
15. bax, but not bcl-2, influences the prognosis of human pancreatic cancer.
Friess H; Lu Z; Graber HU; Zimmermann A; Adler G; Korc M; Schmid RM; Büchler MW
Gut; 1998 Sep; 43(3):414-21. PubMed ID: 9863489
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma and markers of apoptosis (bcl-2, bax, bcl-x): prognostic significance.
Garcia EJ; Lawson D; Cotsonis G; Cohen C
Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):210-7. PubMed ID: 12373145
[TBL] [Abstract][Full Text] [Related]
17. Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX.
Nehls O; Okech T; Hsieh CJ; Enzinger T; Sarbia M; Borchard F; Gruenagel HH; Gaco V; Hass HG; Arkenau HT; Hartmann JT; Porschen R; Gregor M; Klump B
Br J Cancer; 2007 May; 96(9):1409-18. PubMed ID: 17426704
[TBL] [Abstract][Full Text] [Related]
18. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Van den Heuvel MM; Noordzij MA; Nijman RJ; Soliman EH; van Steenbrugge GJ
Br J Cancer; 2001 Nov; 85(10):1557-63. PubMed ID: 11720445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
